indobufen has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dedov, II; Milen'kaia, TM; Shestakova, MV; Tokmakova, AIu; Vykhristiuk, SG | 1 |
| Dmoszyńska-Giannopoulou, A; Ledwozyw, A; Sokołowska, B | 1 |
2 other study(ies) available for indobufen and Autoimmune Diabetes
| Article | Year |
|---|---|
[The thromboxane-synthesis inhibitor Ibustrin in the treatment of diabetic angiopathies].
Topics: Adolescent; Adult; Blood Coagulation; Chronic Disease; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Drug Evaluation; Foot; Humans; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane A2 | 1996 |
[Activation and functions of blood platelets in patients with diabetes mellitus type 1 before and during the treatment with indobufen].
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis | 1990 |